Resumo
Randomized Clinical Trial for Clinical Response Evaluation in Crohn's Disease: Infliximab Versus Adalimumab
Date
2016-03-01Registration in:
Inflammatory Bowel Diseases. Philadelphia: Lippincott Williams & Wilkins, v. 22, p. S30-S30, 2016.
1078-0998
10.1097/01.MIB.0000480181.61935.67
WOS:000393896400092
Author
Fac Med Botucatu
Universidade Estadual Paulista (UNESP)